Description
Descriptions :
The AxenTM Comprehensive Cancer Panels are based on capture hybridization method, providing comprehensive coverage cancer related genes. It is designed to detect clinically actionable genetic alterations in patients with solid tumor and to provide reliable results with evidence of resistance.
Why to test:
Cancer are divided into detailed items according to the gene mutations, which contributes to improved response (about 75% of patients exhibit different effects when the same anti-cancer drug is prescribed) and provides personalized treatment for cancer patients while minimizing adverse effects.
| Genes number | |
| AxenTM Cancer Panel 1 | 88 genes |
| AxenTM Cancer Panel 2 | 171 genes |
| AxenTM Master Cancer Panel | 559 genes |
